日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France

法国专科肿瘤中心对贝伐珠单抗联合紫杉醇与单用紫杉醇一线治疗HER2阴性转移性乳腺癌的成本效益分析

Petitjean, Audrey; Smith-Palmer, Jayne; Valentine, William; Tehard, Bertrand; Roze, Stephané

Extra cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis

非鳞状非小细胞肺癌(NSCLC)患者脑转移(BM)的额外成本:一项基于法国国家医院数据库的分析

Girard, Nicolas; Cozzone, Delphine; de Leotoing, Lucie; Tournier, Charlène; Vainchtock, Alexandre; Tehard, Bertrand; Cortot, Alexis B

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)

法国一项针对符合帕唑帕尼治疗条件的转移性软组织肉瘤 (STS) 患者的全面队列研究的治疗模式和生存情况

Ray-Coquard, Isabelle; Collard, Olivier; Ducimetiere, Françoise; Laramas, Mathieu; Mercier, Florence; Ladarre, Nadine; Manson, Stephanie; Tehard, Bertrand; Clippe, Sébastien; Suchaud, Jean-Philippe; Stefani, Laetitia; Blay, Jean-Yves

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer

一种适用于评估宫颈癌疫苗成本效益的通用模型

Demarteau, Nadia; Detournay, Bruno; Tehard, Bertrand; El Hasnaoui, Abdelkader; Standaert, Baudouin

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study

多项人体测量指标与乳腺癌风险:E3N队列研究结果

Tehard, B; Clavel-Chapelon, F

Anthropometric measurements and body silhouette of women: validity and perception

女性人体测量学指标与体型轮廓:有效性与感知

Tehard, B; van Liere, M J; Com Nougué, C; Clavel-Chapelon, F